Sign in

CIK 0000727510

  • Non-accelerated filer
  • Smaller reporting company

Viskase Holdings, Inc.

Sign in to watch
Ticker
VISK
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222372868
Phone
+1 630-874-0700
Business address
333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
Former names
ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2010-04-03 del Campo Ralph Chief Operating Officer Option exercise +12,600 163,222.14
2010-04-03 del Campo Ralph Chief Operating Officer Shares withheld for taxes −4,463 $10.48 $47K 158,759.14
2010-04-03 del Campo Ralph Chief Operating Officer Option exercise · Restricted Stock Units −12,600 16,800
2010-04-03 HORAK IVAN D President of R&D Option exercise +19,860 59,007
2010-04-03 HORAK IVAN D President of R&D Shares withheld for taxes −7,035 $10.48 $74K 51,972
2010-04-03 HORAK IVAN D President of R&D Option exercise · Restricted Stock Units −19,860 26,480
2010-02-24 TOOMAN CRAIG A Exec. VP Finance, CFO Option exercise +50,000 $6.95 $348K 178,096
2010-02-24 TOOMAN CRAIG A Exec. VP Finance, CFO Option exercise +50,000 $5.73 $287K 228,096
2010-02-24 TOOMAN CRAIG A Exec. VP Finance, CFO Option exercise +50,000 $6.97 $349K 278,096
2010-02-24 TOOMAN CRAIG A Exec. VP Finance, CFO Sale −150,000 $9.27 $1.4M 128,096
2010-02-24 TOOMAN CRAIG A Exec. VP Finance, CFO Option exercise · Stock Option (Right to Buy) −50,000 0
2010-02-24 TOOMAN CRAIG A Exec. VP Finance, CFO Option exercise · Stock Option (Right to Buy) −50,000 0
2010-02-24 TOOMAN CRAIG A Exec. VP Finance, CFO Option exercise · Stock Option (Right to Buy) −50,000 0
2010-02-22 HORAK IVAN D EVP, R&D, CSO Sale −200 $9.34 $2K 140,276
2010-02-22 HORAK IVAN D EVP, R&D, CSO Sale −100 $9.33 $933 140,176
2010-02-22 HORAK IVAN D EVP, R&D, CSO Sale −4,406 $9.33 $41K 135,770
2010-02-22 HORAK IVAN D EVP, R&D, CSO Sale −300 $9.32 $3K 135,470
2010-02-22 HORAK IVAN D EVP, R&D, CSO Sale −1,600 $9.32 $15K 133,870
2010-02-22 HORAK IVAN D EVP, R&D, CSO Sale −100 $9.31 $931 133,770
2010-02-22 HORAK IVAN D EVP, R&D, CSO Sale −8,720 $9.30 $81K 125,050

Page 14 of 25 · 488 trades